AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

Aldebaran Capital, LLC's Holding History (CIK: 0001448430)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 198,508 Value ($000) $2,398 Avg Close $13.58 Range $11.69 - $16.96

Q3 2025

Shares 204,474 Value ($000) $2,779 Avg Close $9.41 Range $5.97 - $15.14

Q2 2025

Shares 217,827 Value ($000) $1,396 Avg Close $4.86 Range $3.11 - $6.70

Q1 2025

Shares 259,253 Value ($000) $918 Avg Close $3.56 Range $2.60 - $4.18

Q4 2024

Shares 262,753 Value ($000) $993 Avg Close $4.71 Range $2.91 - $7.27

Q3 2024

Shares 269,803 Value ($000) $874 Avg Close $2.25 Range $1.62 - $3.33

Q2 2024

Shares 269,803 Value ($000) $513 Avg Close $1.94 Range $1.57 - $2.89

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	198,508	$2,398	$13.58	$11.69 - $16.96
Q3 2025	204,474	$2,779	$9.41	$5.97 - $15.14
Q2 2025	217,827	$1,396	$4.86	$3.11 - $6.70
Q1 2025	259,253	$918	$3.56	$2.60 - $4.18
Q4 2024	262,753	$993	$4.71	$2.91 - $7.27
Q3 2024	269,803	$874	$2.25	$1.62 - $3.33
Q2 2024	269,803	$513	$1.94	$1.57 - $2.89